文献速递神经肿瘤

颅内胶质瘤患者补充疗法与支持措施的使用——门诊前瞻性评估

Use of complementary therapies and supportive measures of patients with intracranial gliomas-a prospective evaluation in an outpatient clinic.
PubMed 文献 · J Neurooncol · 2024-05-06

本研究在门诊对102例颅内胶质瘤患者进行前瞻性横断面描述性调查,评估其对治疗与支持信息的需求及对实验性试验和替代疗法的态度。50%(n=51)未尝试任何附加疗法,营养(25%,n=26)和膳食补充剂(17%,n=17)最常见,14%(n=14)使用替代或补充疗法。年轻年龄(OR 0.96,95%CI 0.92-0.99,p=0.012)和肿瘤实体(4级vs3级OR 5.01,95%CI 1.66-15.11,p=0.004;4级vs其他OR 7.22,95%CI 1.99-26.28,p=0.003)与对补充替代医学(CAM)更大兴趣显著相关。

要点

  • 50%(n=51)胶质瘤患者未尝试附加疗法,营养和膳食补充剂最常见。
  • 14%(n=14)患者使用替代或补充疗法。
  • 年轻患者和WHO 4级肿瘤患者对CAM兴趣显著更高。

核心结论

  • 胶质瘤患者对补充替代医学、营养和膳食补充剂的兴趣高(51%),年轻患者和诊断更差(WHO 4级)者显著更高。
  • 需要包括辅助医学主题的全面信息方法,以提供最佳患者咨询和护理。

研究设计与样本

  • 前瞻性、横断面、描述性调查,在本中心门诊开展,共102例患者参与。
  • 开发了聚焦患者如何获取治疗进一步信息及替代/补充疗法使用的访谈。

主要发现

  • 50%(n=51)患者报告未尝试任何附加疗法。
  • 尝试自我疗法时,最常见为营养(25%,n=26)和膳食补充剂(17%,n=17)。
  • 14%(n=14)患者使用替代或补充疗法。
  • 年轻年龄与对CAM更大兴趣显著相关(OR 0.96,95%CI 0.92-0.99,p=0.012)。
  • 肿瘤实体与对CAM更大兴趣显著相关:4级vs3级肿瘤OR 5.01(95%CI 1.66-15.11,p=0.004),4级vs其他肿瘤OR 7.22(95%CI 1.99-26.28,p=0.003)。

临床怎么用

  • 作者认为需要包括辅助医学主题的全面信息方法,以提供最佳患者咨询和护理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Patients with intracranial gliomas frequently seek for complementary and alternative medicine (CAM), in addition to guideline-directed therapy. In this study, we therefore assessed patients' information needs regarding treatment and support, and evaluated their attitudes toward experimental trials and alternative therapies. METHODS: A prospective, cross-sectional, descriptive survey was conducted in our center. We developed an interview focusing on how patients obtain further information about therapy and the use of alternative/complementary therapies. RESULTS: A total of 102 patients participated in the survey. 50% (n = 51) of patients reported that they had not attempted any additional therapies. When patients attempted self-therapy, it was most commonly in the areas of nutrition (25%, n = 26) and dietary supplements (17%, n = 17). Alternative or complementary therapies were used by 14% (n = 14) of the patients. Younger age (Odds ratio (OR) 0.96 (95% Confidence interval (CI) 0.92-0.99, p = 0.012) and tumor entity (OR 5.01 (95% CI 1.66-15.11, p = 0.004) for grade 4 vs. 3 tumors and OR 7.22 (95% CI 1.99-26.28) for grade 4 vs. other tumors p = 0.003) were significantly associated with a greater interest in CAM. CONCLUSIONS: Interest in complementary and alternative medicine, as well as nutrition and dietary supplements is high (51%) among glioma patients, and significantly higher among younger patients and those with a worse diagnosis (WHO grade 4). A comprehensive approach to information, including paramedical topics, is needed to provide optimal patient counseling and care for glioma patients.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Ottenhausen M, Renovanz M, Bartz I, et al. Use of complementary therapies and supportive measures of patients with intracranial gliomas-a prospective evaluation in an outpatient clinic. J Neurooncol. 2024. PMID: 38709354. doi:10.1007/s11060-024-04696-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。